ClinicalTrials.gov
public full text
Public Domain
Construction of an in Vitro Intestinal Microbial Ecological Simulation System for Obese People
About 2.6 billion people ( about 40 % of the world 's population ) are affected by overweight or obesity. The prevalence of overweight and obesity in Chinese adults has exceeded 50 %, and the prevalence is still on the rise.The gut microbiota is regarded as an endocrine organ and participates in energy balance. Diet changes can disrupt the relationship between the microbiota and the host, leading to metabolic diseases.Although human studies provide important information, there are limitations, such as the entry of complex gastrointestinal environment limiting components, the lack of dynamic microbial process information, and the uncertainty of drug side effects. In vitro methods can solve these problems, allowing dynamic sampling, standardized operation, high repeatability, and evaluation of potential toxins and pathogens. In vitro models are widely used to evaluate the effects on the human colon microbiome and to predict in vivo results.Based on the above research background, this study aims to collect fecal samples from obese people to construct an in vitro intestinal microbial ecological simulation system. This will lay an experimental foundation for further exploring the effect of specific nutrient intervention on the composition and function of gut microbiota in obese people.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases#908353
- Table 5_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353674
- Table 7_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353675
- Table 6_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353673
- Table 9_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353680
Record · ID 1351107
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive